{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:25:09Z","timestamp":1787131509330,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07104-y","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:24:42Z","timestamp":1780683882000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In mantle cell lymphoma, whether 18\u00a0F-FDG PET\/CT or flow cytometry provide superior diagnostic performance compared to biopsy in the determination of bone marrow involvement and enhance prognostic predictive value"],"prefix":"10.1007","volume":"105","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengHan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziteng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"7104_CR1","unstructured":"Swerblow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues (ed 4th) [M]. Lyon: IARC: :229\u2013232"},{"issue":"3","key":"7104_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1470-2045(00)00255-2","volume":"2","author":"I Barista","year":"2001","unstructured":"Barista I, Romaguera JE, Cabanillas F (2001) Mantle-cell lymphoma. Lancet Oncol 2(3):141\u2013148. https:\/\/doi.org\/10.1016\/S1470-2045(00)00255-2","journal-title":"Lancet Oncol"},{"issue":"11","key":"7104_CR3","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/cam4.1205","volume":"6","author":"TH Chen-Liang","year":"2017","unstructured":"Chen-Liang TH, Mart\u00edn-Santos T, Jerez A et al (2017) Bone marrow biopsy superiority over PET\/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma. Cancer Med 6(11):2507\u20132514. https:\/\/doi.org\/10.1002\/cam4.1205","journal-title":"Cancer Med"},{"issue":"5","key":"7104_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12185-021-03080-3","volume":"113","author":"Y Saiki","year":"2021","unstructured":"Saiki Y, Tomita N, Uchida A et al (2021) Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography. Int J Hematol 113(5):675\u2013681. https:\/\/doi.org\/10.1007\/s12185-021-03080-3","journal-title":"Int J Hematol"},{"issue":"7","key":"7104_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.7150\/jca.23714","volume":"9","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhou M, Liu J, Huang G (2018) Prognostic Value of Bone Marrow FDG Uptake Pattern of PET\/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma. J Cancer 9(7):1231\u20131238. https:\/\/doi.org\/10.7150\/jca.23714","journal-title":"J Cancer"},{"issue":"27","key":"7104_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"7104_CR7","doi-asserted-by":"publisher","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer DA, Aleman BMP, Andr\u00e9 M et al (2018) Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv19\u2013iv29. https:\/\/doi.org\/10.1093\/annonc\/mdy080","journal-title":"Ann Oncol"},{"issue":"9","key":"7104_CR8","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/annonc\/mdy250","volume":"29","author":"CA Voltin","year":"2018","unstructured":"Voltin CA, Goergen H, Baues C et al (2018) Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann Oncol 29(9):1926\u20131931. https:\/\/doi.org\/10.1093\/annonc\/mdy250","journal-title":"Ann Oncol"},{"issue":"3","key":"7104_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00259-013-2623-4","volume":"41","author":"HJA Adams","year":"2014","unstructured":"Adams HJA, Kwee TC, de Keizer B, Fijnheer R, de Klerk JMH, Nievelstein RAJ (2014) FDG PET\/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 41(3):565\u2013574. https:\/\/doi.org\/10.1007\/s00259-013-2623-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7104_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2967\/jnumed.112.114710","volume":"54","author":"L Berthet","year":"2013","unstructured":"Berthet L, Cochet A, Kanoun S et al (2013) In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET\/CT provides better diagnostic performance and prognostic stratification than does biopsy. J Nucl Med 54(8):1244\u20131250. https:\/\/doi.org\/10.2967\/jnumed.112.114710","journal-title":"J Nucl Med"},{"issue":"1","key":"7104_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hon.2127","volume":"33","author":"O Wolach","year":"2015","unstructured":"Wolach O, Fraser A, Luchiansky M et al (2015) Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study. Hematol Oncol 33(1):42\u201347. https:\/\/doi.org\/10.1002\/hon.2127","journal-title":"Hematol Oncol"},{"key":"7104_CR12","doi-asserted-by":"publisher","first-page":"100778","DOI":"10.1016\/j.blre.2020.100778","volume":"47","author":"M Sorigue","year":"2021","unstructured":"Sorigue M, Ca\u00f1amero E, Miljkovic MD (2021) Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry. Blood Rev 47:100778. https:\/\/doi.org\/10.1016\/j.blre.2020.100778","journal-title":"Blood Rev"},{"issue":"3","key":"7104_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1365-2559.2007.02961.x","volume":"52","author":"D Talaulikar","year":"2008","unstructured":"Talaulikar D, Shadbolt B, Bell J et al (2008) Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective. Histopathology 52(3):340\u2013347. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02961.x","journal-title":"Histopathology"},{"issue":"10","key":"7104_CR14","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1080\/10428194.2019.1587755","volume":"60","author":"U Greenbaum","year":"2019","unstructured":"Greenbaum U, Levi I, Madmoni O et al (2019) The prognostic significance of bone marrow involvement in diffuse large B cell lymphoma according to the flow cytometry. Leuk Lymphoma 60(10):2477\u20132482. https:\/\/doi.org\/10.1080\/10428194.2019.1587755","journal-title":"Leuk Lymphoma"},{"key":"7104_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood-2012-12-473389","volume":"122","author":"AB Khan","year":"2013","unstructured":"Khan AB, Barrington S, Mikhaeel NG et al (2013) PET-CT staging of DLBCL accurately identifies and provides new insight into the clinical significance of bone marrow involvement. Blood 122:61\u201367. https:\/\/doi.org\/10.1182\/blood-2012-12-473389","journal-title":"Blood"},{"key":"7104_CR16","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1200\/JCO.2012.42.4036","volume":"30","author":"TC El-Galaly","year":"2012","unstructured":"El-Galaly TC, d\u2019Amore F, Mylam KJ et al (2012) Routine bone marrow biopsy has little or no therapeutic consequences for positron emission tomography\/computed tomography-staged treatment-na\u00efve patients with Hodgkin Lymphoma. J Clin Oncol 30:4508\u20134514","journal-title":"J Clin Oncol"},{"issue":"9","key":"7104_CR17","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1182\/blood.V91.9.3340","volume":"91","author":"R Carr","year":"1998","unstructured":"Carr R, Barrington SF, Madan B et al (1998) Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91(9):3340\u20133346","journal-title":"Blood"},{"issue":"20","key":"7104_CR18","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.18.01799","volume":"37","author":"SF Barrington","year":"2019","unstructured":"Barrington SF, Phillips EH, Counsell N et al (2019) Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study. J Clin Oncol 37(20):1732\u20131741. https:\/\/doi.org\/10.1200\/JCO.18.01799","journal-title":"J Clin Oncol"},{"issue":"10","key":"7104_CR19","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.2967\/jnumed.113.134486","volume":"55","author":"JJ Cerci","year":"2014","unstructured":"Cerci JJ, Gy\u00f6rke T, Fanti S et al (2014) Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphoma. J Nucl Med 55(10):1591\u20131597. https:\/\/doi.org\/10.2967\/jnumed.113.134486","journal-title":"J Nucl Med"},{"issue":"3","key":"7104_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-6576.2008.01874.x","volume":"53","author":"Y Lid\u00e9n","year":"2009","unstructured":"Lid\u00e9n Y, Landgren O, Arn\u00e9r S, Sj\u00f6lund KF, Johansson E (2009) Procedure-related pain among adult patients with hematologic malignancies. Acta Anaesthesiol Scand 53(3):354\u2013363. https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01874.x","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"7104_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00277-011-1353-6","volume":"91","author":"J Hong","year":"2012","unstructured":"Hong J, Lee Y, Park Y et al (2012) Role of FDG-PET\/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma. Ann Hematol 91(5):687\u2013695. https:\/\/doi.org\/10.1007\/s00277-011-1353-6","journal-title":"Ann Hematol"},{"issue":"5","key":"7104_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/COC.0b013e318168d90b","volume":"31","author":"AA Muslimani","year":"2008","unstructured":"Muslimani AA, Farag HL, Francis S et al (2008) The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Am J Clin Oncol 31(5):409\u2013412. https:\/\/doi.org\/10.1097\/COC.0b013e318168d90b","journal-title":"Am J Clin Oncol"},{"issue":"24","key":"7104_CR23","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.3390\/cancers16244189","volume":"16","author":"I R\u00f3denas Qui\u00f1onero","year":"2024","unstructured":"R\u00f3denas Qui\u00f1onero I, Marco-Ayala J, Ortu\u00f1o FJ et al (2024) The Value of Bone Marrow Assessment by FDG PET\/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort Study. Cancers (Basel) 16(24):4189. https:\/\/doi.org\/10.3390\/cancers16244189","journal-title":"Cancers (Basel)"},{"issue":"5","key":"7104_CR24","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.3390\/cancers12051138","volume":"12","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Riedl CC, Sch\u00f6der H et al (2020) [18F]FDG-PET\/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients. Cancers (Basel) 12(5):1138. https:\/\/doi.org\/10.3390\/cancers12051138","journal-title":"Cancers (Basel)"},{"key":"7104_CR25","doi-asserted-by":"publisher","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. ;32(27):3048\u20133058. https:\/\/doi.org\/10.1200\/JCO.2013.53.5229","DOI":"10.1200\/JCO.2013.53.5229"},{"issue":"7","key":"7104_CR26","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ajh.23730","volume":"89","author":"HJA Adams","year":"2014","unstructured":"Adams HJA, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RAJ, de Klerk JMH (2014) Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma. Am J Hematol 89(7):726\u2013731. https:\/\/doi.org\/10.1002\/ajh.23730","journal-title":"Am J Hematol"},{"issue":"3","key":"7104_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/MNM.0000000000001139","volume":"41","author":"AA Kandeel","year":"2020","unstructured":"Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y (2020) Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET\/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. Nucl Med Commun 41(3):269\u2013279. https:\/\/doi.org\/10.1097\/MNM.0000000000001139","journal-title":"Nucl Med Commun"},{"issue":"1","key":"7104_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s13139-019-00630-w","volume":"54","author":"J Wang","year":"2020","unstructured":"Wang J, Kim D, Kang WJ, Cho H (2020) Prognostic Value of Bone Marrow F-18 FDG Uptake in Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma. Nucl Med Mol Imaging 54(1):28\u201334. https:\/\/doi.org\/10.1007\/s13139-019-00630-w","journal-title":"Nucl Med Mol Imaging"},{"issue":"10","key":"7104_CR29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.clml.2017.06.010","volume":"17","author":"P Vishnu","year":"2017","unstructured":"Vishnu P, Wingerson A, Lee M, Mandelson MT, Aboulafia DM (2017) Utility of Bone Marrow Biopsy and Aspirate for Staging of Diffuse Large B Cell Lymphoma in the Era of Positron Emission Tomography With 2-Deoxy-2-[Fluorine-18]fluoro-deoxyglucose Integrated With Computed Tomography. Clin Lymphoma Myeloma Leuk 17(10):631\u2013636. https:\/\/doi.org\/10.1016\/j.clml.2017.06.010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"7104_CR30","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/j.clml.2019.04.016","volume":"19","author":"D Albano","year":"2019","unstructured":"Albano D, Ferro P, Bosio G et al (2019) Diagnostic and Clinical Impact of Staging 18F-FDG PET\/CT in Mantle-Cell Lymphoma: A Two-Center Experience. Clin Lymphoma Myeloma Leuk 19(8):e457\u2013e464. https:\/\/doi.org\/10.1016\/j.clml.2019.04.016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"7104_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3343\/alm.2015.35.2.187","volume":"35","author":"B Kim","year":"2015","unstructured":"Kim B, Lee ST, Kim HJ, Kim SH (2015) Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma. Ann Lab Med 35(2):187\u2013193. https:\/\/doi.org\/10.3343\/alm.2015.35.2.187","journal-title":"Ann Lab Med"},{"issue":"29","key":"7104_CR32","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.3760\/cma.j.cn112137-20230223-00259","volume":"103","author":"Y Hong","year":"2023","unstructured":"Hong Y, Wan WL, Li M et al (2023) [Diagnostic and prognostic values of flow cytometry in diffuse large B-cell lymphoma with bone marrow involvement]. Zhonghua Yi Xue Za Zhi 103(29):2258\u20132265. https:\/\/doi.org\/10.3760\/cma.j.cn112137-20230223-00259","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"2","key":"7104_CR33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558\u2013565. https:\/\/doi.org\/10.1182\/blood-2007-06-095331","journal-title":"Blood"},{"issue":"11","key":"7104_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1200\/JCO.2010.33.3419","volume":"29","author":"LH Sehn","year":"2011","unstructured":"Sehn LH, Scott DW, Chhanabhai M et al (2011) Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 29(11):1452\u20131457. https:\/\/doi.org\/10.1200\/JCO.2010.33.3419","journal-title":"J Clin Oncol"},{"issue":"7","key":"7104_CR35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/annonc\/mdx097","volume":"28","author":"A Younes","year":"2017","unstructured":"Younes A, Hilden P, Coiffier B et al (2017) International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol 28(7):1436\u20131447. https:\/\/doi.org\/10.1093\/annonc\/mdx097","journal-title":"Ann Oncol"},{"issue":"36","key":"7104_CR36","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1200\/JCO.20.02287","volume":"38","author":"P Jain","year":"2020","unstructured":"Jain P, Dreyling M, Seymour JF, Wang M (2020) High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management. J Clin Oncol 38(36):4302\u20134316. https:\/\/doi.org\/10.1200\/JCO.20.02287","journal-title":"J Clin Oncol"},{"issue":"9","key":"7104_CR37","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1182\/blood.2023023525","volume":"144","author":"C Malinverni","year":"2024","unstructured":"Malinverni C, Bernardelli A, Glimelius I et al (2024) Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>\u200924 months): the LATE-POD study. Blood 144(9):1001\u20131009. https:\/\/doi.org\/10.1182\/blood.2023023525","journal-title":"Blood"},{"key":"7104_CR38","doi-asserted-by":"crossref","unstructured":"Spurgeon S, Mei M, Barr PM et al (2023) P1200: Zilovertamab Vedotin (Mk-2140). Relapsed or refractory (R\/R) non-Hodgkin lymphoma (Nhl): Updated results from the phase 1 Waveline-001 study [J]. HemaSphere. e54506b2.","DOI":"10.1097\/01.HS9.0000971696.54506.b2"},{"issue":"10","key":"7104_CR39","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1200\/JCO.23.02214","volume":"42","author":"M Wang","year":"2024","unstructured":"Wang M, Siddiqi T, Gordon LI et al (2024) Lisocabtagene Maraleucel in Relapsed\/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study. J Clin Oncol 42(10):1146\u20131157. https:\/\/doi.org\/10.1200\/JCO.23.02214","journal-title":"J Clin Oncol"},{"issue":"1","key":"7104_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12935-025-03789-9","volume":"25","author":"Z Ouyang","year":"2025","unstructured":"Ouyang Z, Zeng R, Wang S et al (2025) Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma. Cancer Cell Int 25(1):172. https:\/\/doi.org\/10.1186\/s12935-025-03789-9","journal-title":"Cancer Cell Int"},{"issue":"9","key":"7104_CR41","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/s41375-025-02688-2","volume":"39","author":"R Dondolin","year":"2025","unstructured":"Dondolin R, Garrou F, Almasri M et al (2025) Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma. Leukemia 39(9):2207\u20132214. https:\/\/doi.org\/10.1038\/s41375-025-02688-2","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07104-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07104-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:33:37Z","timestamp":1787128417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07104-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7104"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07104-y","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study follows the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Ethics No.:2023-KY-1018). Written informed consent has been obtained from the patient(s) to publish this paper.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author and other contributors declare that there are no conflicts of interest, and they have not received any inappropriate employment or financial benefits.","order":3,"name":"Ethics","label":"<b>Conflict of interest<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"359"}}